FDA Inspection 1097997 — Biomat USA Inc

Biomat USA Inc — FEI 3011610718

The FDA completed an inspection of Biomat USA Inc on July 19, 2019 in Pasco, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pasco, WA (United States)

Citations

IDCFRDescription
1809321 CFR 630.10(g)(1)Proof Of Identity